Diseases, Disorders information

Atypical Squamous Cells of Undetermined Significance. The atypical squamous cells of undetermined significance (ASCUS) category is restricted to those slides in which the cellular changes exceed those that can be attributed to reactive or reparative processes, but that fall short of a definitive diagnosis of a squamous intraepithelial lesion. The report should be further qualified, if possible, to indicate whether a reactive process or a squamous intraepithelial lesion is favored. Hyperkeratosis, parakeratosis, and dys-keratosis are descriptors that are not included in the Bethesda System terminology.
Canadian pharmacy cialis
The ASCUS category remains controversial. In August 1992, the National Cancer Institute Early Detection Branch invited clinical experts to participate in a workshop to develop interim guidelines for the management of women with abnormal cervical cytology. This workshop concluded that an ASCUS report should be expected in no more than 5% of Pap test samples. A greater frequency was thought to represent overuse of that diagnosis. Data collected from a Pap test questionnaire survey from the College of American Pathologists have been published. The median rate of ASCUS reports in 1992 was 2.9%, with 10% of laboratories reporting rates greater than 9%. The interim guidelines suggest that the rate of ASCUS should be two to three times the rate of squamous intraepithelial lesion.

Low-Grade Squamous Intraepithelial Lesion. The category of low-grade squamous intraepithelial lesion encompasses human papillomavirus (HPV) and mild dysplasia/cervical intraepithelial neoplasia (CIN) I. The inclusion of the cellular changes supportive of HPV infection (previously termed koilocytosis, koilocytotic atypia, or condylomatous atypia) in the category of low-grade squamous intraepithelial lesion requires that the diagnosis be based on specific cellular criteria to avoid overinterpretation of non-specific artifactual changes mimicking koilocytosis. A cytoplasmic halo without the typical “raisinoid” eccentric nucleus should not be interpreted as koilocytosis.
Online cheap pharmacy
Cellular changes associated with HPV are included in the category of low-grade squamous intraepithelial lesion because the natural history and cytologic features of both HPV and CIN I (mild dysplasia) lesions are similar. Long-term follow-up studies have shown that 14% of lesions previously classified as koilocytosis progress to high-grade intraepithelial neoplasia, and lesions classified as mild dysplasia progress to high-grade lesions in 16% of cases. There is a lack of interobserver and intraobserver reproducibility in differentiating between koilocytosis and CIN I. Thus, from the epidemiologic, virologic, and morphologic standpoints, HPV and CIN I should be grouped together as low-grade squamous intraepithelial lesion.
Breast cancer
High-Grade Intraepithelial Lesion. The category of high-grade intraepithelial lesion encompasses moderate and severe dysplasia, carcinoma in situ/CIN II, and CIN III. The rationale for combining CIN II and CIN 11I into the category of high-grade intraepithelial lesion is also based on biologic and virologic studies. The HPV mix of the two lesions is similar, and the separation of the two lesions has been irreproducible in inter- and intraobserver studies. In addition, the management of CIN II and III is similar, so the separation serves no useful clinical purpose. Although the Bethesda System advocates the two-tier system for squamous intraepithelial lesions, it does not preclude the addition of further subclassification of the lesion for those cytopathologists who wish to retain the degrees of dysplasia or grades of CIN.

Squamous Cell Carcinoma. A report of squamous cell carcinoma indicates the probable presence of an invasive tumor. The qualifier “microinvasive squamous cell carcinoma” may be used by those laboratories that are confident with such a diagnosis.

Unsatisfactory for Evaluation

The “unsatisfactory for evaluation” designation indicates that the specimen is unreliable for the detection of cervical abnormalities and a repeat specimen should be obtained. If abnormal cells are detected in a specimen, the specimen is never categorized as unsatisfactory.

General Categorization

This category allows a clinician to evaluate a Pap test quickly. Three choices are provided: “within normal limits,” “benign cellular changes,” and “epithelial cell abnormality.” A descriptive diagnosis is used to further categorize changes that are other than normal. If infectious or reactive changes (benign cellular changes) are identified along with an epithelial cell abnormality, the specimen is categorized according to the most clinically significant lesion.

Descriptive Diagnoses

Benign Cellular Changes
Diseases information
In this category, the Bethesda System provides for those samples that show changes consistent with infection or repair. Several infections may be identified cytologically with high specificity: trichomoniasis, yeast, and changes consistent with bacterial vaginosis. Changes associated with chlamydial infections should not be reported due to the low specificity of these changes. The term “reactive changes” is used to report cellular findings that are consistent with a reactive or reparative process, such as inflammation resulting from radiation or an intrauterine device.

The Bethesda System
Online Canada Pharmacy
In December 1988, the National Cancer Institute held a workshop in Bethesda, Maryland, to address the standardization of cervical and vaginal cytology reports to facilitate peer review and quality assurance. From this workshop, the Bethesda System for cytologic reporting was developed.

The Bethesda System report includes three general categories:

1. Adequacy of the specimen

2. General categorization

3. Descriptive diagnoses

Adequacy of the Specimen

Satisfactory for Evaluation

A statement that the specimen is “satisfactory” indicates that it includes all of the following: appropriate labeling and identification, relevant clinical information, adequate numbers of interpretable squamous epithelial cells, and an adequate endocervical or transformation zone component. Well-preserved and well-visualized squamous cells should be spread over more than 10% of the slide surface.

Satisfactory for Evaluation but Limited by
Cancer treatment
The clarification “satisfactory for evaluation but limited by” indicates that any of the following apply: lack of pertinent clinical information accompanying the slide or inability to interpret more than 50% of the epithelial cells due to obscuring blood, inflammation, poor fixation, air drying, or contaminant. There should be at least two clusters of well-preserved endocervical or squamous metaplas-tic cells, with each cluster composed of at least five cells. The report indicates that the specimen can be interpreted; however, the interpretation is compromised. Determination of specimen adequacy is ultimately the responsibility of the clinician who correlates the findings of the cytology report with the clinical status of the patient. The absence of an endocervical or transformation zone component does not necessarily require a repeat Pap test. Data from the literature are thus far inconclusive with regard to the endocervical component as a measure of adequacy. Short-term longitudinal studies have demonstrated no increase in the frequency of subsequent squamous lesions among women whose initial specimens lacked endocervical cells.